Alzheimer's Drug Discovery Foundation

SpeechDx

Who can apply: Qualified researchers and institutions whose proposed work aligns with SpeechDx's mission and ethical requirements may apply for access. The data may be used for speech-based analyses, and access is provided in a protected controlled environment. ADDF negotiates investment terms for non-exclusive dataset access.

Deadline: Applications for data access are not given a fixed deadline; data access is subject to review and negotiated terms.

Therapeutics Funding Programs (ADDF)

Who can apply: Open to academic centers and biotechs advancing therapeutic and biomarker development for Alzheimer's and related dementias. Specific eligibility varies by RFP.

Deadline: Letter of Intent: September 14, 2026; Invited Full Proposal: TBD

Prevention RFP (Therapeutics Prevention Pipeline)

Who can apply: Projects testing prevention approaches or whether drug use/choice affects dementia risk. See RFP for details.